AI Visibility Report Details How Patients Can Find Your Brand

AI platforms reshape patient discovery in medical aesthetics, new index finds.

A new industry report from Haute Living finds that artificial intelligence platforms are rapidly replacing social media as the primary entry point for patient research in medical aesthetics, shifting how brands and providers are discovered and evaluated.

The Medical Aesthetics AI Visibility Index 2026, released April 27 by communications firm 5WPR in partnership with Haute MD, analyzed more than 60 patient-intent queries across ChatGPT, Claude, Perplexity and Google AI Overviews to rank 25 leading brands by “AI citation share.”

The report concludes that “patients no longer start with Instagram. They start with AI,” marking a significant departure from a decade of social-driven marketing in the category.

Visibility is concentrated, with the top 15 brands capturing about 62% of AI citations.

The index shows a high concentration of visibility among a small group of companies. Botox, Juvéderm, CoolSculpting, SkinCeuticals and Morpheus8 ranked as the most frequently cited brands across AI-generated answers, reflecting strong alignment between clinical authority and AI discoverability.

Overall, the top 15 brands account for about 62% of total AI citation share, leaving the remaining visibility fragmented among smaller brands, unranked competitors and individual provider mentions.

The report identifies this concentration as a structural shift in how patients encounter brands, with AI systems favoring established companies that have extensive clinical data, regulatory documentation and long-form editorial coverage.

AI platforms are replacing social media as the starting point for patient research in aesthetics.

Both the report and its accompanying coverage highlight a behavioral change among higher-end consumers. Patients who previously relied on Instagram feeds, influencer content and before-and-after imagery are now asking direct questions through generative AI tools and reading synthesized answers as their first touchpoint.

Industry factors contributing to the shift include reduced targeting capabilities on social platforms, tighter content moderation policies around cosmetic procedures and the rise of conversational search interfaces.

As a result, AI-generated responses are increasingly functioning as the “first consultation,” influencing which brands and treatments patients consider before contacting a provider.

GLP-1–related demand is shaping both treatment interest and AI recommendations.

The index also links AI visibility patterns to broader treatment demand trends tied to GLP-1 weight-loss medications such as semaglutide and tirzepatide.

According to the findings, increased use of these drugs is driving higher interest in procedures related to facial volume restoration, skin tightening and body contouring, and these shifts are already reflected in AI-generated recommendations.

The report notes that this demand surge is occurring within a global medical aesthetics market valued at about $22 billion, with rapid growth in related procedures such as facial fat grafting and dermal fillers.

Established brands with strong clinical and editorial presence dominate AI answers.

A key takeaway for practices and brands is the reported disconnect between traditional marketing investment and AI visibility performance.

Some established companies with strong sales and practitioner adoption are underrepresented in AI answers due to limited presence in the types of sources large language models prioritize, including peer-reviewed studies, FDA-cleared product information and authoritative editorial coverage.

Conversely, brands with sustained clinical documentation and educational content are more consistently surfaced across AI platforms, suggesting that citation-based authority is outweighing paid media reach in determining visibility.

What these findings mean for med spa marketing funnels

The findings indicate that AI platforms are becoming a primary channel for top-of-funnel patient acquisition. For medical aesthetics practices, this shift may affect how patients select treatments, brands and providers, as well as how practices position their expertise online.

The report frames AI citation presence as analogous to referral visibility, with inclusion in AI-generated answers influencing consultation volume, treatment adoption and long-term patient value.

While the study focuses on brand-level performance, it also notes that some AI citations reference individual dermatology and plastic surgery practices, indicating potential opportunities for provider-level visibility within AI-driven search results.